Bernd Schnabl
University of California San Diego · 377 works · 33,224 citations · h-index 89
Top works
- Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth
- Bacterial infections in cirrhosis: A position statement based on the EASL Special Conference 2013
- Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits
- Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice
- Interactions Between the Intestinal Microbiome and Liver Diseases
- Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease
- Enteric dysbiosis associated with a mouse model of alcoholic liver disease
- MyD88-mediated signals induce the bactericidal lectin RegIIIγ and protect mice against intestinal Listeria monocytogenes infection
- The gut–liver axis and the intersection with the microbiome
- Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis
- New mitochondrial DNA synthesis enables NLRP3 inflammasome activation
- Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance
- Acute-on-chronic liver failure in cirrhosis
- Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease
- The Role of Smad3 in Mediating Mouse Hepatic Stellate Cell Activation
- Replicative Senescence of Activated Human Hepatic Stellate Cells Is Accompanied by A Pronounced Inflammatory But Less Fibrogenic Phenotype
- CD40 Activates NF-κB and c-Jun N-Terminal Kinase and Enhances Chemokine Secretion on Activated Human Hepatic Stellate Cells
- Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease
- Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut
- The gut–liver axis and gut microbiota in health and liver disease